We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$408B
AUM Growth
+$23B
Cap. Flow
+$1.72B
Cap. Flow %
0.42%
Top 10 Hldgs %
28.09%
Holding
14,143
New
3,275
Increased
5,446
Reduced
4,187
Closed
1,034

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$627M
2
BIDU icon
Baidu
BIDU
+$542M
3
MBB icon
iShares MBS ETF
MBB
+$492M
4
NVDA icon
NVIDIA
NVDA
+$429M
5
CMCSA icon
Comcast
CMCSA
+$421M

Sector Composition

Rank Sector Weight
1 Technology 3.73%
2 Healthcare 3.22%
3 Consumer Discretionary 2.4%
4 Financials 2.32%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMAR icon
11376
Vision Marine Technologies
VMAR
$4.71M
0
PDYNW icon
11377
Palladyne AI Corp Warrants
PDYNW
$185K
$219K ﹤0.01%
+335,818
New +$241K
EIGR
11378
CALL
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$219K ﹤0.01%
823
-1,684
-67% -$531K
CORR
11379
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$219K ﹤0.01%
30,917
+9,551
+45% +$76.3K
AQST icon
11380
CALL
Aquestive Therapeutics
AQST
$492M
$218K ﹤0.01%
41,900
+27,600
+193% +$147K
BBVA icon
11381
CALL
Banco Bilbao Vizcaya Argentaria
BBVA
$155B
$218K ﹤0.01%
41,700
+29,600
+245% +$156K
EVER icon
11382
PUT
EverQuote
EVER
$839M
$218K ﹤0.01%
6,000
-1,000
-14% -$42.6K
IMOS
11383
CALL
ChipMOS TECHNOLOGIES
IMOS
$1.83B
$218K ﹤0.01%
+6,900
New +$185K
KURA icon
11384
PUT
Kura Oncology
KURA
$824M
$218K ﹤0.01%
7,700
-16,600
-68% -$525K
MRM
11385
MEDIROM Healthcare Technologies
MRM
$7.24M
$218K ﹤0.01%
+19,626
New +$248K
BGRY
11386
PUT
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$218K ﹤0.01%
+21,500
New +$232K
AGRX
11387
PUT
DELISTED
Agile Therapeutics
AGRX
$218K ﹤0.01%
52
+24
+86% +$130K
CYBE
11388
CALL
DELISTED
Cyberoptics Corp
CYBE
$218K ﹤0.01%
+8,400
New +$218K
TYME
11389
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$218K ﹤0.01%
+122,402
New +$254K
JHMF
11390
DELISTED
John Hancock Multifactor Financials ETF
JHMF
$218K ﹤0.01%
+4,631
New +$206K
APLE icon
11391
PUT
Apple Hospitality REIT
APLE
$3.77B
$217K ﹤0.01%
+14,900
New +$207K
CAPR icon
11392
Capricor Therapeutics
CAPR
$242M
$217K ﹤0.01%
46,298
+9,595
+26% +$55.3K
TSLX icon
11393
CALL
Sixth Street Specialty
TSLX
$1.78B
$217K ﹤0.01%
+10,300
New +$221K
XTNT icon
11394
Xtant Medical Holdings
XTNT
$62.1M
$217K ﹤0.01%
91,973
+24,917
+37% +$53.2K
SCU
11395
PUT
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$217K ﹤0.01%
+9,900
New +$196K
ACGN
11396
PUT
DELISTED
Aceragen Inc
ACGN
$217K ﹤0.01%
+9,851
New +$738K
DGNS
11397
PUT
DELISTED
Dragoneer Growth Opportunities Corp. II Class A Ordinary Shares
DGNS
$217K ﹤0.01%
+21,100
New +$250K
QTS
11398
CALL
DELISTED
QTS REALTY TRUST, INC.
QTS
$217K ﹤0.01%
3,500
-4,300
-55% -$268K
KOLD icon
11399
PUT
ProShares UltraShort Bloomberg Natural Gas
KOLD
$105M
$216K ﹤0.01%
550
-1,160
-68% -$443K
MAX icon
11400
MediaAlpha
MAX
$756M
$216K ﹤0.01%
6,100
-273,456
-98% -$13.6M

Similar funds

Citadel Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Citadel Advisors held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q1 2021 filing shows 3,275 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
  • Citadel Advisors added most to Amazon in Q1 2021, an estimated $627M increase.
  • Citadel Advisors's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
  • Citadel Advisors fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
  • Citadel Advisors's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
  • Citadel Advisors opened 3,275 new positions and closed 1,034 in Q1 2021.
  • Citadel Advisors's portfolio value rose 6% quarter-over-quarter to $408B.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.